These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
734 related items for PubMed ID: 15297424
1. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S. Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424 [Abstract] [Full Text] [Related]
2. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S, Meyer E, Debatin KM. Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673 [Abstract] [Full Text] [Related]
7. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Glaser T, Wagenknecht B, Weller M. Oncogene; 2001 Aug 09; 20(35):4757-67. PubMed ID: 11521188 [Abstract] [Full Text] [Related]
8. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A. Gynecol Oncol; 2004 Jun 09; 93(3):594-604. PubMed ID: 15196850 [Abstract] [Full Text] [Related]
9. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling. Kamarajan P, Sun NK, Chao CC. Biochem J; 2003 Nov 15; 376(Pt 1):253-60. PubMed ID: 12911332 [Abstract] [Full Text] [Related]
10. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T, Takata Y, Kagawa S, Roth JA, Tschopp J, Tanaka N. Oncogene; 2001 Aug 23; 20(37):5225-31. PubMed ID: 11526513 [Abstract] [Full Text] [Related]
11. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells. Abe H, Shibata MA, Otsuki Y. Mol Hum Reprod; 2006 Sep 23; 12(9):535-41. PubMed ID: 16870953 [Abstract] [Full Text] [Related]
15. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A, Coutant A, Baffet G, Peter ME, Fardel O, Guguen-Guillouzo C. Carcinogenesis; 2005 Dec 23; 26(12):2086-94. PubMed ID: 16033771 [Abstract] [Full Text] [Related]
16. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome. Bagnoli M, Ambrogi F, Pilotti S, Alberti P, Ditto A, Barbareschi M, Galligioni E, Biganzoli E, Canevari S, Mezzanzanica D. Endocr Relat Cancer; 2009 Jun 23; 16(2):443-53. PubMed ID: 19321593 [Abstract] [Full Text] [Related]
17. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
18. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Krammer PH, Rösl F. Oncogene; 2002 Jan 10; 21(2):165-75. PubMed ID: 11803460 [Abstract] [Full Text] [Related]
19. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S. Gynecol Oncol; 2005 May 10; 97(2):353-64. PubMed ID: 15863130 [Abstract] [Full Text] [Related]
20. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Hossain DM, Banerjee S, Das K, Sa G, Das T. Carcinogenesis; 2010 Feb 10; 31(2):259-68. PubMed ID: 19969555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]